Is this you?
Request access for Del Sol Research Management with your @bitrialsupport.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall64Recruit59Ops65Sponsor68Ther67
Performance (observed)
Historical trials
210
Completed
97
Terminated/Withdrawn
28
Completion rate
78%
Active now
82
Phase 2
49
Phase 3
152
Realized enrollment
495,422
First study year
2007
Years active
19
Match confidence
high
Enrollment velocity (inf)
26,075
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
187
States
Arizona
Recruitment (web observed)
Capability notes
5 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
AbbVie; Boehringer Ingelheim; Pfizer; Merck Sharp & Dohme LLC; Eli Lilly and Company; Amgen
CROs
IQVIA Pvt. Ltd; PPD Development, LP; PPD, Part of Thermo Fisher Scientific; Premier Research; Teva Branded Pharmaceutical Products R&D LLC; Worldwide Clinical Trials
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
unitedstates@bitrialsupport.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 5 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall64
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.